Stock analysis, AI verdict, fundamentals & technical signals
Rating: BUY
Price: $9.49 Analyst target: $27.75 Upside: 192.41%
MeiraGTx Holdings plc, a clinical-stage gene therapy company, focused on developing treatments for patients living with serious illnesses. The company is headquartered in New York, New York.
See the full interactive analysis & chart →Informational only — not investment advice.